↓ Skip to main content

The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery

Overview of attention for article published in Frontiers in Medicine, January 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery
Published in
Frontiers in Medicine, January 2017
DOI 10.3389/fmed.2016.00075
Pubmed ID
Authors

Anna Karawajczyk, Kristina M. Orrling, Jon S. B. de Vlieger, Ton Rijnders, Dimitrios Tzalis

Abstract

The European Lead Factory (ELF) is a public-private partnership (PPP) that provides researchers in Europe with a unique platform for translation of innovative biology and chemistry into high-quality starting points for drug discovery. It combines an exceptional collection of small molecules, high-throughput screening (HTS) infrastructure, and hit follow-up capabilities to advance research projects from both private companies and publicly funded researchers. By active interactions with the wider European life science community, ELF connects and unites bright ideas, talent, and experience from several disciplines. As a result, ELF is a unique, collaborative lead generation engine that has so far resulted in >4,500 hit compounds with a defined biological activity from 83 successfully completed HTS and hit evaluation campaigns. The PPP has also produced more than 120,000 novel innovative library compounds that complement the 327,000 compounds contributed by the participating pharmaceutical companies. Intrinsic to its setup, ELF enables breakthroughs in areas with unmet medical and societal needs, where no individual entity would be able to create a comparable impact in such a short time.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 24%
Student > Master 9 17%
Student > Ph. D. Student 8 15%
Other 4 7%
Librarian 2 4%
Other 4 7%
Unknown 14 26%
Readers by discipline Count As %
Chemistry 15 28%
Biochemistry, Genetics and Molecular Biology 5 9%
Business, Management and Accounting 4 7%
Agricultural and Biological Sciences 3 6%
Immunology and Microbiology 3 6%
Other 8 15%
Unknown 16 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2022.
All research outputs
#8,161,049
of 26,383,519 outputs
Outputs from Frontiers in Medicine
#2,165
of 7,533 outputs
Outputs of similar age
#134,948
of 426,435 outputs
Outputs of similar age from Frontiers in Medicine
#15
of 31 outputs
Altmetric has tracked 26,383,519 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 7,533 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,435 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.